Related Experiment Video
Updated: Dec 20, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The role of a Coronavirus disease 2019 pharmacist: an Australian perspective
Jenny Nguy1, Sarah A Hitchen2, Adam L Hort2
1Department of Pharmacy, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, WA, 6150, Australia. jenny.nguy@health.wa.gov.au.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has greatly impacted healthcare services around the world. Pharmacists are front-line healthcare professionals and integral members of the healthcare team. The deployment of a specialized 'COVID pharmacist' within our institution has demonstrated that the skills of the pharmacist can be adapted, expanded and utilized to alleviate the pressure of doctor shortages, reduce healthcare worker exposure to infected patients, contribute to therapeutic decisions and work collaboratively to tackle the challenges faced during this pandemic. This commentary details an Australian hospital pharmacy response to the COVID-19 pandemic, describing the unique clinical and practical contributions made by a specialized COVID pharmacist in our institution.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Coronary Artery Disease V: Interprofessional Care
Drug Control Governance: Regulatory Bodies and Their Impact
Biopharmaceutics and Pharmacokinetics: Overview
Acute Coronary Syndrome IV: Interprofessional Care
Pharmacokinetics: Drug–Food and Drug–Viral Interactions

